Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen
Conditions: Cirrhosis, Liver; Vaccination Failure; HBV; Vaccine Reaction Interventions: Drug: IMIQUIMOD cream; Biological: HEPATITIS B SURFACE ANTIGEN Sponsor: Central Hospital, Nancy, France Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cirrhosis | France Health | Hepatitis | Hepatitis B | Hepatitis Vaccine | Hospitals | Liver | Research | Urology & Nephrology | Vaccines